Novo Nordisk’s new Wegovy pill hit the market this week. The Danish drug maker, best known for GLP-1 injections like Ozempic ...
A growing body of research suggests that some dreams might indicate the existence of physiologic changes before conventional ...
After almost 40 years in nursing, much of it spent in cardiology, using a defibrillator machine was second nature to Fran ...
The U.S. Food and Drug Administration (FDA) will meet Cognition during a Type C meeting scheduled for the second half of January 2026. During the meeting, the next clinical studies for zervimesine in ...
The organisation said: "The person with early symptoms of dementia may notice the signs themselves, or family, friends and ...
Background Dementia with Lewy bodies (DLB) is the second most common neurodegenerative dementia, yet it remains under-recognised and misdiagnosed, which delays treatment, causes inaccurate prognosis ...
“His first misperceptions occurred when he was in a nightclub; the skin of the other dancers, even their faces, seemed to be covered with tattoos. At first, he thought the tattoos were real, but they ...
Lewy body dementia (LBD) is a type of dementia that gets worse over time. It is the second most common neurodegenerative disease after Alzheimer’s disease, but it can be hard to diagnose. It is a ...
Welcome to Neurotransmissions, a new First Opinion column on the revolution in dementia. This is the second in a three-part series on the dramatically changing world of dementia. Read the first part ...
Objective: To investigate the association between gait parameters and cognitive decline in patients with dementia with Lewy bodies (DLB) and evaluate the impact of gait abnormalities on fall risk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback